Angioimmunoblastic T cell lymphoma: Treatment exerience with cyclosporine

Leukemia and Lymphoma

Volumn 48, Issue 3, 2007, Pages 521-525

  Advani, Ranjana ^a   Horwitz, Steven ^b   Zelenetz, Andrew ^b   Horning, Sandra J ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cyclosporine; Refractory AILT; T cell lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; IMMUNOGLOBULIN G; PREDNISONE; PROCARBAZINE; RITUXIMAB; STEROID; SURAMIN; VINCRISTINE;

ADULT; AGED; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ARTICLE; CANCER REGRESSION; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CREATININE BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG MEGADOSE; DRUG RESPONSE; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; HYPERTENSION; INFECTION; KIDNEY FAILURE; MAINTENANCE DRUG DOSE; MALE; PHARYNGITIS; PRIORITY JOURNAL; SIDE EFFECT; T CELL LYMPHOMA; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOBLASTIC LYMPHADENOPATHY; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 33947699888     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190601137658     Document Type: Article

References (26)

1. Harris, N. L., Jaffe, E. S., Diebold, J., Flandrin, G., Muller-Hermelink, H. K. and Vardiman, J. (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol, 17, pp. 3835-3849.
2. Rudiger, T., Weisenburger, D. D., Anderson, J. R., Armitage, J. O., Diebold, J. and MacLennan, K. A. (2002) Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): Results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol, 13, pp. 140-149.
3. Pautier, P., Devidas, A., Delmer, A., Dombret, H., Sutton, L. and Zini, J. M. (1999) Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literature. Leuk Lymphoma, 32, pp. 545-552.
4. Reiser, M., Josting, A., Soltani, M., Staib, P., Salzberger, B. and Diehl, V. (2002) T-cell non-Hodgkin's lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factors. Leuk Lymphoma, 43, pp. 805-811.
5. Savage, K. J., Chhanabhai, M., Gascoyne, R. D. and Connors, J. M. (2004) Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol, 15, pp. 1467-1475.
6. Ferry, J. A. (2002) Angioimmunoblastic T-cell lymphoma. Adv Anat Pathol, 9, pp. 273-279.
7. Ohshima, K., Haraoka, S., Suzumiya, J., Kawasaki, C., Kanda, M. and Kikuchi, M. (2000) Cytoplasmic cytokines in lymphoproliferative disorders: Multiple cytokine production in angioimmunoblastic lymphadenopathy with dysproteinemia. Leuk Lymphoma, 38, pp. 541-545.
8. Pizzolo, G., Vinante, F., Agostini, C., Zambello, R., Trentin, L. and Masciarelli, M. (1987) Immunologic abnormalities in angioimmunoblastic lymphadenopathy. Cancer, 60, pp. 2412-2418.
9. Siegert, W., Agthe, A., Griesser, H., Schwerdtfeger, R., Brittinger, G. and Engelhard, M. (1992) Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/ IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group. Ann Intern Med, 117, pp. 364-370.
10. Dogan, A., Attygalle, A. D. and Kyriakou, C. (2003) Angioimmunoblastic T-cell lymphoma. Br J Haematol, 121, pp. 681-691.
11. Schetelig, J., Fetscher, S., Reichle, A., Berdel, W. E., Beguin, Y. and Brunet, S. (2003) Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Haematologica, 88, pp. 1272-1278.
12. Murayama, T., Imoto, S., Takahashi, T., Ito, M., Matozaki, S. and Nakagawa, T. (1992) Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with Cyclosporin A. Cancer, 69, pp. 2567-2570.
13. Takemori, N., Kodaira, J., Toyoshima, N., Sato, T., Sakurai, H. and Akakura, N. (1999) Successful treatment of immunoblastic lymphadenopathy-like T-cell lymphoma with Cyclosporin A. Leuk Lymphoma, 35, pp. 389-395.
14. Advani, R., Warnke, R., Sikic, B. I. and Horning, S. (1997) Treatment of angioimmunoblastic T-cell lymphoma with cyclosporine. Ann Oncol, 8, pp. 601-603.
15. Carbone, P. P., Kaplan, H. S., Musshoff, K., Smithers, D. W. and Tubiana, M. (1971) Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res, 31, pp. 1860-1861.
16. (1993) A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med, 329, pp. 987-994.
17. Han, C. W., Imamura, M., Hashino, S., Zhu, X., Tanaka, J. and Imai, K. (1995) Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression. Bone Marrow Transplant, 15, pp. 733-739.
18. 2+, calcineurin, and NF-AT. Cell, 96, pp. 611-614.
19. Jones, D., O'Hara, C., Kraus, M. D., Perez-Atayde, A. R. and Shahsafaei, A. (2000) Expression pattern of T-cell associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood, 96, pp. 685-690.
20. Grogg, K. L., Attygalle, A. D., Macon, W. R., Remstein, E. D., Kurtin, P. J. and Dogan, A. (2005) Angioimmunoblastic T-cell lymphoma: A neoplasm of germinal-center T-helper cells?. Blood, 106, pp. 1501-1502.
21. Yamamura, M., Honda, M., Yamada, Y., Itoyama, T., Sohda, H. and Yubashi, T. (1996) Increased levels of interleukin-6 (IL-6) in serum and spontaneous in vitro production of IL-6 by lymph node mononuclear cells of patients with angio-immunoblastic lymphadenopathy with dysproteinemia (AILD), and clinical effectiveness of cyclosporin A. Leukemia, 10, pp. 1504-1508.
22. Weiss, L. M., Jaffe, E. S., Liu, X. F., Chen, Y. Y., Shibata, D. and Medeiros, L. J. (1992) Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood, 79, pp. 1789-1795.
23. Luzzatto, F., Pruneri, G., Benini, E., Manzotti, M., Laszlo, D. and Martinelli, G. (2005) Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres and a high content of EBV-infected large B-cells carrying IgH chain gene monoclonal rearrangement. Histopathology, 46, pp. 464-466.
24. Quintanilla-Martinez, L., Fend, F., Moguel, L. R., Spilove, L., Beaty, M. W. and Kingma, D. W. (1999) Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection. Am J Surg Pathol, 23, pp. 1233-1240.
25. Brauninger, A., Spieker T., Willenbrock, K., Gaulard, P., Wacker, H. H. and Rajewsky, K. (2001) Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) epstein-barr virus-infected b cells in angioimmunoblastic t cell lymphoma. J Exp Med, 194, pp. 927-940.
26. Battegay, M., Berger, C., Rochlitz, C., Hurwitz, N., Hirsch, H. H. and De Geyter, C. (2004) Epstein-Barr virus load correlating with clinical manifestation and treatment response in a patient with angioimmunoblastic T-cell lymphoma. Antivir Ther, 9, pp. 453-459.